Subscribe to Email Alerts
Menu
About Us
Company
Cancer Diagnostics Market
Board
Executive
Advisors
Partners
Distributors
Careers
Technology
Our Technologies
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® (RUO)
FAQ
Pipeline
Diagnostics Pipeline
Investors
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
Snapshot
Heading &
Sub-heading can be edited through HQI
Investors
>
Snapshot
Snapshot
ASX Announcements
Reports
Presentations
Share Price Information
Analyst Coverage
Corporate Governance
Finance News Network Videos
Snapshot
Company
INOVIQ Ltd
Description
INOVIQ Ltd is a lifesciences company developing and commercialising diagnostic and exosome-based solutions to improve the diagnosis and treatment of cancer and other diseases
Headquarters
Melbourne, Australia
ASX Code
ASX:IIQ (listed 20 June 2016)
Sector
Healthcare
Shares on issue
92,018,702 as at 20/12/21
Board
Dr Geoff Cumming
Chairman
Robert (Max) Johnston
Non-Executive Director
Philip Powell
Non-Executive Director
Professor Allan Cripps
Non-Executive Director
Key Management
Dr Leearne Hinch
Chief Executive Officer
Dr Greg Rice
Chief Scientific Officer
Tony Di Pietro
CFO & Company Secretary
